Clinical Trials Logo
  1. Home
  2. Organ Transplantation
  3. NCT00149981

A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Organ Transplantation Clinical Trial

Official title:
A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

Clinical Trial Summary

Facilitated access to everolimus until it is commercially available and reimbursable by appropriate parties

Clinical Trial Description

This is a treatment protocol designed only to provide access to everolimus (RAD) for maintenance immunosuppression. The objectives are to facilitate the management of patients on maintenance immunosuppression therapy who are completing everolimus trials,

- To provide everolimus maintenance therapy through this access program and

- To collect and review safety data for up to 120 months or until the project has been discontinued whichever comes first.

- To collect and review safety data for up to 120 months or when Certican is commercially available in the given indication and reimbursed by appropriate payors or the project has been discontinued whichever comes first. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00149981
Study type Expanded Access
Source Novartis
Contact
Status No longer available
Phase
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT00987103 - Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients Phase 1
Completed NCT03699839 - Reducing the Burden of Influenza After Solid-Organ Transplantation Phase 2/Phase 3
Completed NCT01633424 - The "Stanford Integrated Psychosocial Assessment for Transplant" (SIPAT)
Completed NCT01254955 - Antibody Production Following H1N1 Influenza Vaccination in Organ Transplant Patients N/A
Completed NCT00948883 - Study of Cancers After Solid Organs Transplants N/A
Recruiting NCT02314949 - Leuven Tolerogenic Protocol for Intestinal Transplantation N/A
Recruiting NCT01283295 - Immune Monitoring and Assay Development in Organ Transplant Recipients
Not yet recruiting NCT03861962 - Re-evaluation of Donor-specific Anti-HLA Alloantibodies Immunoassay After Organ Transplantation, From Antigen Level to Epitope Level
Completed NCT01123187 - Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation N/A
Completed NCT00213304 - The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation Phase 3
Completed NCT01515072 - Remote Ischemic Preconditioning in Neurological Death Organ Donors N/A
Completed NCT00904579 - Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease
Recruiting NCT04687865 - Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)
Recruiting NCT00611494 - Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors Phase 4
Completed NCT02852902 - Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study.
Completed NCT05685888 - Effect of Ursodeoxycholic Acid on Preventing Covid-19 Infection in Patients With Organ Transplantation
Recruiting NCT00792064 - Systematic Evaluation of Predictors of Quality of Life in the Long-term After Solid Organ Transplantation N/A
Completed NCT00734396 - Mesenchymal Stem Cells and Subclinical Rejection Phase 1/Phase 2
Completed NCT00286871 - Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen Phase 1
Recruiting NCT03997253 - Optimizing Long-term Survival in Organ Transplantation: From Physiopathology to Optimized Patient Management N/A